# Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma

> **NCT01339975** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 310 (estimated)

## Conditions studied

- Carcinoma
- Carcinoma Renal Cell
- Kidney Neoplasms
- Kidney Diseases
- Chemokines

## Interventions

- **BIOLOGICAL:** Biological sample
- **BIOLOGICAL:** Biological sample

## Key facts

- **NCT ID:** NCT01339975
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-06
- **Primary completion:** 2014-05
- **Final completion:** 2019-05
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339975, "Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01339975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*